Arrr mateys, the potion for thar cursed Factor Xa be a bit hit 'n miss in ICH trials. Aye!
2024-05-15
Arrr! The latest findings from the ANNEXA-I trial have been unveiled in the grand NEJM! 'Tis a tale of better control over bloody hematoma expansion, but a rise in treacherous thrombotic events with andexanet versus the usual care. 'Tis a fine read for those with a taste for medical adventures! Arrr!
Arrr me hearties! Listen up ya scurvy dogs! The results of the ANNEXA-I trial be in, and it looks like we be havin' better control of hematoma expansion with this new drug called andexanet. But beware, there be a catch! Seems like there be an increase in them thrombotic events compared to the usual care. Aye, it be a tricky situation we find ourselves in.So, me mateys, ye best be weighin' the risks and benefits before ye go dabblin' in this new fangled medicine. Don't want to be endin' up with more problems than ye started with, now do ye? Keep a weather eye on those thrombotic events, lest ye find yerself in Davy Jones' locker!
These findings be published in the prestigious NEJM, so ye can trust they be true. But remember, just because it be in print don't mean it be foolproof. Consult with yer trusty physician before makin' any decisions about yer health.
So there ye have it me hearties! Keep a weather eye on them thrombotic events and make sure ye be weighin' the risks and benefits before ye go messin' with this new drug. Fair winds and followin' seas to ye all!